SCHEDULE OF SEGMENT INFORMATION (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Segment Reporting Information [Line Items]
Revenue	$ 998,828	$ 4,960,711	$ 3,166,093	$ 12,173,964
Cost of Sales			(2,376,944)	(8,438,149)
Gross Profit (Loss)			789,149	3,735,815
Operating Expenses			(10,055,706)	(9,775,579)
Operating Income (Loss)	(2,578,978)	(963,781)	(9,266,557)	(6,039,764)
Other Income (Expense)	$ 4,547,503	$ 2,433,020	(7,068,004)	(954,752)
Net Income (Loss) Before Income Tax			(16,334,561)	(6,994,516)
Real Estate Segment [Member]
Segment Reporting Information [Line Items]
Revenue			2,126,737	10,997,704
Cost of Sales			(1,905,090)	(7,882,274)
Gross Profit (Loss)			221,647	3,115,430
Operating Expenses			(1,369,966)	(1,321,120)
Operating Income (Loss)			(1,148,319)	1,794,310
Other Income (Expense)			1,621	11,784
Net Income (Loss) Before Income Tax			(1,146,698)	1,806,094
Digital Transformation Technology [Member]
Segment Reporting Information [Line Items]
Revenue			151
Cost of Sales			(223)
Gross Profit (Loss)			(72)
Operating Expenses			(448,809)	(421,543)
Operating Income (Loss)			(448,881)	(421,543)
Other Income (Expense)			(1,488,079)	(1,935,969)
Net Income (Loss) Before Income Tax			(1,936,960)	(2,357,512)
Biohealth Business [Member]
Segment Reporting Information [Line Items]
Revenue
Cost of Sales				(3,409)
Gross Profit (Loss)				(3,409)
Operating Expenses			(446,268)	(910,354)
Operating Income (Loss)			(446,268)	(913,763)
Other Income (Expense)			(2,624,116)	(923,595)
Net Income (Loss) Before Income Tax			(3,070,384)	(1,837,358)
Other [Member]
Segment Reporting Information [Line Items]
Revenue			1,039,205	1,176,260
Cost of Sales			(471,631)	(552,466)
Gross Profit (Loss)			567,574	623,794
Operating Expenses			(7,790,663)	(7,122,562)
Operating Income (Loss)			(7,223,089)	(6,498,768)
Other Income (Expense)			(2,957,430)	1,893,028
Net Income (Loss) Before Income Tax			$ (10,180,519)	$ (4,605,740)